Injective has been making a lot of impressive advancements in blockchain technology. With its integration with USDC and the launch of their cross-chain transfer protocol, it has added a new payment layer to its features enabling native USDC transactions. The protocol launch and their successful expansion of the blockchain payments stack have resulted in an impressive price increase indicating the potential to be a good long-term investment. In fact, the chart has projected up to 2800% future gains, sparking intrigue in the cryptocurrency community.
Additionally, Canary has updated its staked
Injective ETF with the SEC which could have ramifications for institutional crypto adoption, and not just that, Pineapple Financial has also started migrating its $10B mortgage portfolio onchain via Injective. Meanwhile, key updates on their network have been proposed which could significantly impact the value of the INJ token. On the other hand,
Injective (INJ) faced somewhat of a setback with Binance temporarily suspending INJ deposits and withdrawals due to a network upgrade. Despite this, the protocol continues to work towards propelling its price past $50 by 2030 and the chart suggests that INJ is searching for a footing while $EV2 presale moves through stages. Amidst these advancements, however, INJ token slid 8% after the launch of its buyback protocol. Despite this, the Injective Community remained supportive, even voting to cut INJ supply and boost deflation.
Injective Coin News Analytics from Thu, 03 Mar 2022 03:34:04 GMT to Wed, 18 Mar 2026 02:17:43 GMT -
Rating 8
- Innovation 6
- Information 9
- Rumor -2
